Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19

• Status: Recruiting
• Trial end date: 2020-06-10
• Target enrollment: 0
• Participant gender: All

Summary

As the world faces COVID-19, the search for effective treatments against the disease and its complications has turned its gaze to drugs that are classically used in other infectious diseases. Some drugs are being examined for the recent evidence on its effects on viral replication and inflammation, one is Azithromycin, used to treat a wide variety of bacterial infections, Ivermectin, an anti-parasitic drug and the other is Cholecalciferol to increase serum concentration of 25-hydroxyvitamin D.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
• Treatments: Azithromycin; Cholecalciferol; Ivermectin

Criteria

Inclusion Criteria:

• Confirmed infection of SARS-CoV2 virus

• Mild COVID-19

• Symptoms of respiratory illness

• Cough

• Fever (T >38 °C)

Exclusion Criteria:

• Allergy to any of the drugs treatment